PPD, Inc.

Last updated
PPD, Inc.
Company typeSubsidiary
Industry Contract research organizations
Pharmaceutical
Biotechnology
Founded1985
Headquarters Waltham, Massachusetts, United States
Key people
See Senior Leadership Team page of the PPD Website [1]
ProductsContract clinical research for pharmaceutical, biotechnology, medical device, academic and government organizations; services include drug development, laboratory and lifecycle management.
RevenueIncrease2.svg $4.7 Billion (2020) [2]
Number of employees
40,000+ (2023)
Parent Thermo Fisher Scientific
Website https://www.ppd.com

Pharmaceutical Product Development (PPD) is a global contract research organization (CRO) providing comprehensive, integrated drug development, laboratory and lifecycle management services. In December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific.

Contents

History

PPD was founded by Fred Eshelman, Pharm.D., as a one-person consulting firm in 1985. The following year, he expanded the company's scope to include development services and relocated operations from Maryland to North Carolina.

Location

PPD has its headquarters in Wilmington, North Carolina. The company has more than 27,000 employees. As of December 2021, PPD became a wholly owned subsidiary of Thermo Fisher Scientific, based in Waltham, Massachusetts.

References

  1. ↑ "Senior Leadership Team" . Retrieved 11 May 2021.
  2. ↑ https://www.macrotrends.net/stocks/charts/PPD/ppd/revenue [ dead link ]
  3. ↑ Wayne Faulkner (May 19, 2009). "David Grange named CEO of PPD; Eshelman named executive chairman". Wilmington StarNews.[ permanent dead link ]
  4. ↑ "PPD and Furiex Announce Completion of Spin-off" . Retrieved 12 June 2018.
  5. ↑ Wayne Faulkner (May 20, 2011). "David Grange retires as CEO of PPD". Wilmington StarNews. Archived from the original on August 15, 2014. Retrieved April 22, 2014.
  6. ↑ "PPD appoints Raymond Hill as chief executive officer and member of the board of directors". 12 June 2018.[ permanent dead link ]
  7. ↑ Peter Lattman (October 3, 2011). "Buyout Firms to Buy Drug Research Company for $3.9 Billion". New York Times.
  8. ↑ William Faulkner (May 23, 2012). "PPD names new CEO". Wilmington StarNews. Archived from the original on April 2, 2015. Retrieved April 22, 2014.
  9. ↑ "PPD Acquires Acurian, Industry Leader in Patient Recruitment and Retention". August 27, 2013. Archived from the original on July 13, 2018. Retrieved July 12, 2018.
  10. ↑ John Murawski (December 24, 2014). "PPD enters into joint venture with Japanese company". The News & Observer.
  11. ↑ Ben Adams (September 8, 2016). "PPD ties off Evidera merger deal, establishes 'real world research' leader". FierceBiotech.
  12. ↑ PPD (April 26, 2017). "PPD to Recapitalize with Existing Owners and Investors".
  13. ↑ Melissa Fassbender (July 2, 2018). "PPD flips the patient enrollment model and launches new site solution".
  14. ↑ PPD (July 23, 2018). "Synexus Announces U.S.-Based Registry to Power Major Longitudinal Study on Brain Aging".
  15. ↑ Joseph Keenan (February 28, 2019). "PPD inks deal with China's HLT to create data science-driven research solutions". FierceBiotech.
  16. ↑ Melissa Fassbender (May 30, 2019). "PPD's Evidera acquires RWE provider Medimix". Outsourcing-Pharma.
  17. ↑ PPD (September 5, 2019). "PPD's Accelerated Enrollment Solutions Acquires Global Site Business from Bioclinica".
  18. ↑ Joshua Franklin (February 5, 2020). "Drug research firm PPD prices IPO at top end of target". Reuters.
  19. ↑ "Thermo Fisher buying PPD in deal worth $17.4 billion". AP News. 2021-04-15.
  20. ↑ "Thermo Fisher Scientific Completes Acquisition of PPD, Inc". PR newswire. 2021-12-08.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.